menu search

Design therapeutics to present at the 2023 jefferies healthcare conference

CARLSBAD, Calif., May 31, 2023 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatme...

May 31, 2023, 6:30 am

Krystal clear: krystal biotech clears resistance in good volume

Last week, shares of the Pittsburgh-based genetic medicines developer surged more than 25% after the FD...

May 30, 2023, 7:36 am

Ultragenyx: a promising bet on rare genetic disorder therapies

Ultragenyx's pipeline boasts a diverse array of gene therapy candidates, including UX111, DTX401, DTX301, and UX701, offering transformative potential...

May 29, 2023, 7:15 am

Genetic testing services market anticipated to hit us$ 31.5 billion by 2031, expanding at a cagr of 8.4%: tmr report

The growing awareness about personalized medicines and the increased rate of genetic disorders across t...

May 26, 2023, 9:30 pm

23andme reports fy2023 fourth quarter and full year financial results

Achieved FY2023 financial guidance FY2023 full year revenue grew 10% over prior year Webcast today, May 25, 2023 at 4:30 p.m. Eastern Time SOUTH SAN F...

May 25, 2023, 8:05 pm

Myriad genetics (mygn) adds new test to oncology portfolio

Myriad Genetics (MYGN) expands Precise Oncology Solutions portfolio by adding a new biomarker test....

May 25, 2023, 1:32 pm

Goldman sachs maintains myriad genetics buy recommendation

Fintel reports that on May 24, 2023, Goldman Sachs maintained coverage of Myriad Genetics (NASDAQ:MYGN)...

May 24, 2023, 10:37 pm

Why shares of sarepta therapeutics are dropping wednesday

Sarepta focuses on gene therapies to treat rare diseases. SRP-9001 is designed to correct the genetic m...

May 24, 2023, 1:53 pm

Goldman sachs upgrades myriad genetics

Fintel reports that on May 23, 2023, Goldman Sachs upgraded their outlook for Myriad Genetics (NASDAQ:M...

May 23, 2023, 10:29 pm

Arbor biotechnologies to present at the stifel 2023 tailoring genes: genetic medicines day

CAMBRIDGE, Mass., May 23, 2023 (GLOBE NEWSWIRE) — Arbor Biotechnologies®, a biotechnology company discovering and developing the next generation of...

May 23, 2023, 11:00 am

Verve therapeutics to participate in the stifel 2023 tailoring genes: virtual genetic medicines day

BOSTON, May 23, 2023 (GLOBE NEWSWIRE) — Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiova...

May 23, 2023, 10:30 am

Kalvista pharmaceuticals to present at stifel 2023 tailoring genes: genetic medicines day virtual conference

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)---- $KALV--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical compa...

May 23, 2023, 6:30 am

Baylor genetics announces neuromuscular disorders panel

Latest Panel Analyzes 142 Genes Associated with Hereditary Neuromuscular Disorders HOUSTON, May 22, 2023 (GLOBE NEWSWIRE) — Baylor G...

May 22, 2023, 2:05 pm

Large investors slowed home purchases by late 2022

Large investors, who were buying homes and pricing out home buyers, are no longer investing in the housing market at a fr...

May 22, 2023, 1:50 pm

Krystal biotech stock rises after fda approves treatment for rare skin disease

Krystal Biotech Inc. KRYS, +5.49% shares rose Friday after the biotech drug company received Food and Drug Administration approval of a rare skin dise...

May 19, 2023, 2:39 pm

U.s. fda approves krystal biotech's skin disorder gene therapy

The U.S. Food and Drug Administration on Friday approved Krystal Biotech Inc's topical gene therapy for patients with a g...

May 19, 2023, 2:05 pm

Ultragenyx to present at the 2023 barclays – gene editing & gene therapy summit

NOVATO, Calif., May 19, 2023 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the developmen...

May 19, 2023, 12:30 pm

Ultragenyx to present at the 2023 barclays - gene editing & gene therapy summit

NOVATO, Calif., May 19, 2023 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development...

May 19, 2023, 8:30 am

14.7% cagr of gene panel market is estimated to account for usd 9,345 mn by the end of 2032 | market.us

The gene panel market refers to the industry involved in the development, manufacturing, and distribution of gene panels, which are diagnostic tools u...

May 18, 2023, 10:47 am

Prenetics global limited (pre) flat as market gains: what you should know

Prenetics Global Limited (PRE) closed the most recent trading day at $0.89, making no change from the p...

May 17, 2023, 6:55 pm


Search within

Pages Search Results: